Pharm Plan Minutes 2018.01.19

From IHE Wiki
Jump to: navigation, search

Meeting report

Friday, 19th January 2018 13:00-14:30 CET

Attendees

  • Jose Costa Teixeira
  • Marc Robberecht
  • Stephane Spahni
  • Michael van der Zel
  • Michael Tan



Welcome / Review of the agenda (5 min)

No change in agenda

Schedule for regular TC conf calls

  • For the time being there is no call in May. Instead we plan to have the joint meeting with ISO in Cologne. Not sure whether HL7 Pharmacy will join. This will be discussed with Christian Hay and Michael Tan and HL7 Pharmacy at the HL7 WGM in New Orleans on Tuesday Q1.
  • The location for June has not been confirmed yet. To be discussed in Oslo.

Review of TC work items

  • New work items have not been started yet. Everybody is to busy with other projects.
  • Either Supply or Adverse Event Reporting on the worklist. Priority should also depend on the market need. Are there any vendors willing to implement?

Attendance of IHE Pharmacy in Oslo

Confirmed:

  • Jacqueline Surugue
  • Stephane Spahni
  • Jose Costa Teixeira
  • Esther Peelen
  • Michael van der Zel
  • Michael Tan

Not sure:

  • Jurgen Brandstaetter
  • Leonidas Tzimis
  • Simon Letellier

Absent:

  • Marc Robberecht

Discuss agenda F2F in Oslo

  • Agenda has been reviewed and adjusted directly.

Progress of Connectathon The Hague

  • IHE Europe is responsible for the connectathon in April in The Hague.
  • IHE Netherlands has contacted this team and are preparing the Connectathon.
  • The pharmacy profiles MMA and UBP have been submitted.
  • GS1 is taking the lead to organize the Dutch vendors to participate in the Connectathon.
  • Many Dutch vendors are interested and join the conference call's.
  • The short lead time and the costs make it difficult for vendors to give their commitment.
  • Beside the connectathon IHE is also organizing a projectathon and a we-connect. The Projectathon is more of a trial and without certification.
  • The we connect is more a presentation to explain and show the use cases.